Aphea.Bio raised €70M in a Series C round in Jul 2023. The company is based in Zwijnaarde, Belgium. Investors in the round: Astanor Ventures, Bill & Melinda Gates Foundation Trust , BNP Paribas Fortis and 3 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €70M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
